Plasma inorganic pyrophosphate and alkaline phosphatase in patients with pseudoxanthoma elasticum
- PMID: 32042814
- PMCID: PMC6989879
- DOI: 10.21037/atm.2019.12.73
Plasma inorganic pyrophosphate and alkaline phosphatase in patients with pseudoxanthoma elasticum
Abstract
Background: Inorganic pyrophosphate (PPi) plays a major role inhibiting dystrophic calcification. The aim was to analyze levels of PPi in patients having pseudoxanthoma elasticum (PXE), and controls as well as the enzymes who regulate the PPi plasma concentration.
Methods: We collected fasting blood samples from PXE patients and age- and sex-matched controls in ethylenediamine tetraacetic acid (EDTA) and citrate-theophylline-adenosine-dipyridamole (CTAD) containing tubes. We measured PPi, ENPP1 mass and activity, alkaline phosphatase (AP) and tissue non-specific alkaline phosphatase (TNAP), CD73 and Human Platelet Factor-4 (CXCL4).
Results: PPi in EDTA and CTAD samples were lower in PXE subjects than in controls (1.11±0.26 vs. 1.43±0.41 µM/L and 0.35±0.15 vs. 0.61±0.18 µM/L respectively, P<0.05). TNAP and liver TNAP activities were also higher in PXE than in controls (80.3±27.0 vs. 63.3±16.4 UI/L and 25.6±14.9 vs. 12.9±9.2 UI/L respectively, P<0.05). ENPP1 mass and activity as well as CD73 were almost identical. There was a weak but significant inverse correlation between TNAP activity and PPi levels (Pearson correlation -0.379, P<0.05) in both groups.
Conclusions: High TNAP activity seems to contribute to low plasma levels of PPi in subjects with PXE, reinforcing the idea that pharmacological reduction of TNAP activity may help to reduce dystrophic calcification in PXE patients.
Keywords: CD73; ENPP1; Pseudoxanthoma elasticum (PXE); alkaline phosphatase (AP); calcification; inorganic pyrophosphate (PPi); non-specific tissue alkaline phosphatase (TNAP).
2019 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures


Similar articles
-
Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.J Dermatol Sci. 2014 Aug;75(2):109-20. doi: 10.1016/j.jdermsci.2014.04.015. Epub 2014 May 17. J Dermatol Sci. 2014. PMID: 24907773
-
Fibroblasts from patients affected by Pseudoxanthoma elasticum exhibit an altered PPi metabolism and are more responsive to pro-calcifying stimuli.J Dermatol Sci. 2014 Apr;74(1):72-80. doi: 10.1016/j.jdermsci.2013.12.008. Epub 2014 Jan 2. J Dermatol Sci. 2014. PMID: 24461675
-
Anticalcification effects of DS-1211 in pseudoxanthoma elasticum mouse models and the role of tissue-nonspecific alkaline phosphatase in ABCC6-deficient ectopic calcification.Sci Rep. 2022 Nov 18;12(1):19852. doi: 10.1038/s41598-022-23892-5. Sci Rep. 2022. PMID: 36400944 Free PMC article.
-
The Purinergic Nature of Pseudoxanthoma Elasticum.Biology (Basel). 2024 Jan 26;13(2):74. doi: 10.3390/biology13020074. Biology (Basel). 2024. PMID: 38392293 Free PMC article. Review.
-
ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.Int J Mol Sci. 2021 Apr 27;22(9):4555. doi: 10.3390/ijms22094555. Int J Mol Sci. 2021. PMID: 33925341 Free PMC article. Review.
Cited by
-
Serum Calcification Propensity T50 Associates with Disease Severity in Patients with Pseudoxanthoma Elasticum.J Clin Med. 2022 Jun 28;11(13):3727. doi: 10.3390/jcm11133727. J Clin Med. 2022. PMID: 35807012 Free PMC article.
-
A Fragile Phosphate/Pyrophosphate Balance: From Essential Mineralization to Rare Calcifying Diseases.Curr Osteoporos Rep. 2025 Aug 6;23(1):34. doi: 10.1007/s11914-025-00928-z. Curr Osteoporos Rep. 2025. PMID: 40768170 Review.
-
Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial.Int J Mol Sci. 2023 Mar 3;24(5):4899. doi: 10.3390/ijms24054899. Int J Mol Sci. 2023. PMID: 36902331 Free PMC article. Clinical Trial.
-
Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway.Cells. 2020 Jun 5;9(6):1410. doi: 10.3390/cells9061410. Cells. 2020. PMID: 32517079 Free PMC article.
-
Novel Treatments for PXE: Targeting the Systemic and Local Drivers of Ectopic Calcification.Int J Mol Sci. 2023 Oct 10;24(20):15041. doi: 10.3390/ijms242015041. Int J Mol Sci. 2023. PMID: 37894722 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous